Greenway Announces Filing of its Audited Year-End Financial Statements For the Fiscal Year ended March 31, 2025
Greenway Greenhouse Cannabis (OTCQB:GWAYF) reported strong financial results for fiscal year 2025, with annual net revenue reaching $8.95 million, up 71% year-over-year. The company demonstrated significant improvements in key metrics, including a 107% revenue increase in Q4 to $3.07 million.
Notable achievements include positive adjusted EBITDA of $1.18 million (compared to -$624,391 prior year), improved average sales price of $1.32 per gram (up 40%), and reduced cash cost to $0.83 per gram. The company's cash position strengthened by $1.61 million to $3.14 million, with operating activities generating $1.81 million in net cash compared to -$2.05 million last year.
Greenway Greenhouse Cannabis (OTCQB:GWAYF) ha riportato risultati finanziari solidi per l'anno fiscale 2025, con un fatturato netto annuale che ha raggiunto gli 8,95 milioni di dollari, in aumento del 71% rispetto all'anno precedente. L'azienda ha mostrato miglioramenti significativi nei principali indicatori, incluso un incremento del fatturato del 107% nel quarto trimestre, arrivando a 3,07 milioni di dollari.
Tra i risultati degni di nota si evidenziano un EBITDA rettificato positivo di 1,18 milioni di dollari (rispetto a -624.391 dollari dell'anno precedente), un prezzo medio di vendita migliorato a 1,32 dollari per grammo (in aumento del 40%) e un costo in contanti ridotto a 0,83 dollari per grammo. La posizione di cassa dell'azienda si è rafforzata di 1,61 milioni, raggiungendo 3,14 milioni di dollari, con le attività operative che hanno generato 1,81 milioni di dollari di cassa netta rispetto a -2,05 milioni dell'anno scorso.
Greenway Greenhouse Cannabis (OTCQB:GWAYF) reportó resultados financieros sólidos para el año fiscal 2025, con un ingreso neto anual que alcanzó los 8.95 millones de dólares, un aumento del 71% interanual. La compañía mostró mejoras significativas en métricas clave, incluyendo un incremento del 107% en ingresos en el cuarto trimestre hasta 3.07 millones de dólares.
Logros destacables incluyen un EBITDA ajustado positivo de 1.18 millones de dólares (en comparación con -624,391 dólares del año anterior), un precio promedio de venta mejorado de 1.32 dólares por gramo (un aumento del 40%) y una reducción del costo en efectivo a 0.83 dólares por gramo. La posición de efectivo de la empresa se fortaleció en 1.61 millones, alcanzando 3.14 millones de dólares, con actividades operativas que generaron 1.81 millones de dólares en efectivo neto frente a -2.05 millones del año pasado.
Greenway Greenhouse Cannabis (OTCQB:GWAYF)는 2025 회계연도에 강력한 재무 성과를 보고했으며, 연간 순수익이 895만 달러에 달해 전년 대비 71% 증가했습니다. 회사는 주요 지표에서 큰 개선을 보였으며, 특히 4분기 매출이 107% 증가하여 307만 달러를 기록했습니다.
주요 성과로는 조정 EBITDA가 118만 달러의 긍정적 수치(전년 -624,391달러 대비), 평균 판매 가격이 그램당 1.32달러로 40% 상승, 현금 비용이 그램당 0.83달러로 감소한 점이 있습니다. 회사의 현금 보유액은 161만 달러 증가하여 314만 달러가 되었으며, 영업 활동에서 181만 달러의 순현금을 창출해 작년의 -205만 달러와 대조를 이뤘습니다.
Greenway Greenhouse Cannabis (OTCQB:GWAYF) a annoncé de solides résultats financiers pour l'exercice 2025, avec un chiffre d'affaires net annuel atteignant 8,95 millions de dollars, en hausse de 71 % par rapport à l'année précédente. L'entreprise a démontré des améliorations significatives dans les indicateurs clés, notamment une augmentation des revenus de 107 % au quatrième trimestre pour atteindre 3,07 millions de dollars.
Parmi les réalisations notables figurent un EBITDA ajusté positif de 1,18 million de dollars (contre -624 391 dollars l'année précédente), un prix de vente moyen amélioré à 1,32 dollar par gramme (en hausse de 40 %) et un coût en espèces réduit à 0,83 dollar par gramme. La trésorerie de l'entreprise s'est renforcée de 1,61 million pour atteindre 3,14 millions de dollars, les activités opérationnelles générant 1,81 million de dollars de flux de trésorerie net contre -2,05 millions l'année dernière.
Greenway Greenhouse Cannabis (OTCQB:GWAYF) meldete starke Finanzergebnisse für das Geschäftsjahr 2025, mit einem jährlichen Nettoumsatz von 8,95 Millionen US-Dollar, was einem Anstieg von 71 % im Jahresvergleich entspricht. Das Unternehmen zeigte deutliche Verbesserungen bei wichtigen Kennzahlen, darunter ein Umsatzanstieg von 107 % im vierten Quartal auf 3,07 Millionen US-Dollar.
Bemerkenswerte Erfolge umfassen ein positives bereinigtes EBITDA von 1,18 Millionen US-Dollar (im Vergleich zu -624.391 US-Dollar im Vorjahr), einen verbesserten durchschnittlichen Verkaufspreis von 1,32 US-Dollar pro Gramm (plus 40 %) und reduzierte Baraufwendungen auf 0,83 US-Dollar pro Gramm. Die Barposition des Unternehmens stärkte sich um 1,61 Millionen auf 3,14 Millionen US-Dollar, wobei die operative Tätigkeit 1,81 Millionen US-Dollar an Nettobarmitteln generierte, verglichen mit -2,05 Millionen im Vorjahr.
- None.
- Posted annual net loss of $2.06 million
- Significant interest expense of $1.10 million
- Recorded impairment of intangible asset of $35,913
The Company is pleased to report the following results for the year ended March 31, 2025. All amounts are expressed in Canadian dollars:
- Annual net revenue of
$8,948,943 71% compared to the prior year. Fourth quarter net revenue was$3,071,106 107% from the same quarter in the prior fiscal year - Total grams or grams equivalent sold during the fiscal year were 6,803,628, representing a
23% increase year-over-year. - Annual average sales price of
$1.32 40% from the prior year with a fourth quarter average sales price of$1.46 - Average cash cost per gram sold of
$0.83 $0.73 - Adjusted EBITDA of
$1,181,419 $624,391 - Excluding amounts due to related parties, the Company had a positive working capital of
$3,997,814 $3,283,911 - Net cash provided by operating activities was
$1,806,461 $2,047,081 - The Company achieved a net income for the fourth quarter of
$202,729 - Cash balance increased by
$1,612,088 $3,142,898
"This past year marks a true turning point for Greenway. Our
A copy of the audited annual financial statements for the year ended March 31, 2025 (prepared in accordance with IFRS Accounting Standards ("IFRS")) and the related Management's Discussion and Analysis are available under the Company's profile on www.sedarplus.ca.
Non-IFRS Measures
Management uses a non-IFRS measure to assess the Company's performance. Non-IFRS measures do not have any standardized meaning under IFRS and are not a measure of financial performance under IFRS, and therefore, may not be comparable to similar measures presented by other companies. Please refer to page 1 of the Company's Management's Discussion and Analysis for an explanation of the composition of Adjusted EBITDA, an explanation of how it provides useful information to an investor and a quantitative reconciliation to the most directly comparable financial measure under IFRS, all of which is hereby incorporated by reference in this press release.
Reconciliations of Non-IFRS Measures
The following table reconciles the non-IFRS measure to the most comparable IFRS measure for the year ended March 31, 2025. This measure does not have any standardized meaning under IFRS and is not a measure of financial performance under IFRS, and therefore, may not be comparable to similar measures presented by other companies.
For the year ended March 31, 2025 | |
Net Loss and Comprehensive Loss | (2,057,449) |
Amortization - Cost of sales | 1,677,631 |
Fair value adjustment on sale of inventory | 289,458 |
Fair value adjustment on growth of biological assets | (370,467) |
Amortization – Operating expenses | 418,131 |
Shares issued for services rendered | 88,783 |
Bad debt | 954 |
Impairment of intangible asset | 35,913 |
Interest expense | 1,098,510 |
$ | |
Adjusted EBITDA | 1,181,419 |
This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities in
Greenway Greenhouse Cannabis Corporation is a federally licensed cultivator for the Canadian cannabis marketplace. Greenway is headquartered in
The CSE has in no way passed upon the merits of the business of the Company and has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
Cautionary Note Regarding Forward-Looking Statements
This news release contains forward-looking statements that constitute forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements in this news release that are not purely historical statements of fact are forward-looking statements and include statements regarding the Offering and the intended use of proceeds thereof, and the Company's beliefs, plans, expectations, future, strategy, objectives, goals and targets, the development of future operations, and orientations regarding the future as of the date of this news release. Although the Company believes that such statements are reasonable and reflect expectations of future developments and other factors which management believes to be reasonable and relevant, the Company can give no assurance that such expectations will prove to be correct. Forward- looking statements are typically identified by words such as: "believes", "expects", "aim", "anticipates", "intends", "estimates", "plans", "may", "should", "would", "will", "potential", "scheduled" or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved.
Forward-looking statements involve known and unknown risks, assumptions, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements, and includes those risks described in the Company's final prospectus dated September 3, 2021, a copy of which is available under the Company's profile at www.sedarplus.ca. Forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements
View original content to download multimedia:https://www.prnewswire.com/news-releases/greenway-announces-filing-of-its-audited-year-end-financial-statements-for-the-fiscal-year-ended-march-31-2025-302511328.html
SOURCE Greenway Greenhouse Cannabis Corporation
FAQ
What was Greenway Cannabis (GWAYF) revenue growth in fiscal year 2025?
What was GWAYF's EBITDA and cash flow performance in FY 2025?
How much did Greenway's cannabis sales price improve in 2025?
What was Greenway's (GWAYF) production cost per gram in 2025?
What was Greenway's net income/loss for fiscal year 2025?
